Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (6)

2020

  1. Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

    Drugs in Context, Vol. 9

  2. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

    Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Role of rivaroxaban in the prevention of atherosclerotic events

    Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 771-780

2011

  1. Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

    Cancer, Vol. 117, Núm. 24, pp. 5529-5537

2009

  1. Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: A comparison of presenting clinical characteristics and response to treatment

    Annals of Hematology, Vol. 88, Núm. 10, pp. 973-978